Irvine, CA (PRWEB) April 11, 2013
EP Global Communications, Inc. (the Company), (Stock Ticker: EPGL) will be among the first Medical Device Makers to Implement Google Glass technology and the API Mirror platform for use with its medical devices. EPGL Medical, a new medical device maker specializing in advanced technology for innovative hand-held medical devices, has several new devices in development under direction of David T. Markus Ph.D., which are being developed with the latest smart platforms in mind. "Physicians using our devices will be able to utilize technology such as Google Glass while performing procedures, using our devices and viewing feedback data in real-time." Said David T. Markus, Ph.D. "The advancement of these exceptional new technologies are ideal for medical applications as doctors need a hands-free reference to feedback data while performing procedures." Markus said.
In addition to integrating smart technology such as Google Glass, EPGL Medical now has a "secret weapon" medical device technology advancement which no other medical device company has. This single technology will be the catalyst for dozens of new medical device technologies to be produced or licensed by the Company. The Company is in the process of filing more than 50 patents to protect this unique and valuable innovation. "It so happens that our new devices are being developed right at the same time very cool smart technologies such as Google Glass are in their infancy". Said Company President Michael Hayes. "It makes sense to embrace this technology fully and use it to make EPGL medical devices even smarter. Every new device concept we are developing will benefit from the integration of smart technology."
In addition to the new technologies EPGL is progressing, the Company is implementing an innovative new approach to medical device marketing with a business model which guarantees residual income from each new device sold. The Company's VIP approach to its physician customers with on-going technical support and educational training, will build strong loyalty to our medical devices.
Additionally, EPGL is making it as attractive as possible to purchase our devices by giving doctors and hospitals several affordable options for their purchase including, outright purchase, leasing and financing options. These options combined with the newly established CPT coding for our first device; MPDD, will make it easier than ever for doctors to build a business around EPGL medical devices.
About EP Global Communications, Inc. / EPGL Medical
EP Global Communications, Inc. is a medical device manufacturer and marketing company with exclusive rights to a new FDA 510k cleared medical device called the Muscle Pain Detection Device. The MPDD is a revolutionary new diagnostic tool for the detection of muscular originated pain in the human body.
Safe Harbor Statement
Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.